Permitted Use and Disclosures. Each Party hereto may use or disclose Confidential Information disclosed to it by the other Party or Results to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder in filing or prosecuting Patent applications, prosecuting or defending litigation, complying with applicable governmental laws, rules, regulations or court order or otherwise submitting information to tax or other governmental authorities, conducting clinical trials, or making a permitted sublicense or otherwise exercising license rights expressly granted by the other Party to it pursuant to the terms of this Agreement; provided, that if a Party is required to make any such disclosure, other than pursuant to a confidentiality agreement, it will give reasonable advance notice to the other Party of such disclosure and, save to the extent inappropriate in the case of Patent applications, will use its reasonable efforts to secure confidential treatment of such information in consultation with the other Party prior to its disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements. Nothing in this Article 10 shall restrict TESARO from providing Development Antibodies (and associated related information) to academic and other collaborators to conduct pre-clinical and clinical studies to further the research, development and commercialization of the Development Antibodies.
Appears in 6 contracts
Samples: Collaboration and Exclusive License Agreement, Collaboration and Exclusive License Agreement (Anaptysbio Inc), Collaboration and Exclusive License Agreement (Anaptysbio Inc)
Permitted Use and Disclosures. Each Party hereto party may use or disclose Confidential Information disclosed to it by the other Party party to the extent such information is included in the Firmenich Technology, Senomyx Technology or Results Joint Patent Rights, and to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder in filing or prosecuting Patent patent applications, prosecuting or defending litigation, complying with applicable governmental lawsregulations, rules, regulations or court order orders or otherwise submitting information to tax or other governmental authorities, conducting clinical trialstaste testing, submitting information for regulatory applications, or making a permitted sublicense or otherwise exercising license rights expressly granted by to the other Party to it party pursuant to the terms of this Agreement; provided, however, that if a Party party is required to make any such disclosuredisclosure of the other party’s Confidential Information, other than pursuant to a confidentiality agreement, it will give reasonable advance notice of such disclosure to the other Party of such disclosure party where reasonably possible and, save to the extent inappropriate in the case of Patent patent applications, will use its reasonable efforts to secure confidential treatment of such information Confidential Information in consultation with the other Party party prior to its such disclosure (whether through protective orders or otherwise) and disclose only ). Any disclosure of Confidential Information shall be limited to the minimum necessary to comply with such requirements. Nothing in this Article 10 shall restrict TESARO from providing Development Antibodies (and associated related information) to academic and other collaborators to conduct pre-clinical and clinical studies to further the research, development and commercialization of the Development Antibodies.
Appears in 4 contracts
Samples: Collaborative Research, Development, Commercialization and License Agreement (Senomyx Inc), Collaborative Research, Development, Commercialization and License Agreement (Senomyx Inc), Collaborative Research, Development, Commercialization and License Agreement (Senomyx Inc)
Permitted Use and Disclosures. Each Party hereto party may use or disclose Confidential Information disclosed to it by the other Party party
i) to the extent such information is included in the PEPSICO Technology, SENOMYX Technology or Results Joint Patent Rights, and
ii) to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder in in:
a) filing or prosecuting Patent patent applications, ;
b) prosecuting or defending litigation, ;
c) complying with applicable governmental lawsregulations, rules, regulations or court order orders or otherwise submitting information to tax or other governmental authorities, ;
d) conducting clinical trials, trials or other safety studies for Selected Compounds or other regulatory approval applications for Selected Compounds;
e) submitting information for food additive approval applications or other regulatory approval applications for Selected Compounds; or
f) making a permitted sublicense or otherwise exercising license rights expressly granted by to the other Party to it party pursuant to the terms of this Agreement; provided, that if . If a Party party is required to make any such disclosure, disclosure of the other than pursuant to a confidentiality agreementparty’s Confidential Information as described in this Section 13.7, it will give reasonable advance notice of such disclosure to the other Party of such disclosure and, save to the extent inappropriate in the case of Patent applications, party where reasonably possible and will use its reasonable efforts to secure confidential treatment of such information Confidential Information in consultation with the other Party party prior to its such disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements. Nothing in this Article 10 shall restrict TESARO from providing Development Antibodies (and associated related information) to academic and other collaborators to conduct pre-clinical and clinical studies to further the research, development and commercialization of the Development Antibodies.
Appears in 3 contracts
Samples: Collaborative Research, Development, Commercialization and License Agreement (Senomyx Inc), Collaborative Research, Development, Commercialization and License Agreement (Senomyx Inc), Collaborative Research, Development, Commercialization and License Agreement (Senomyx Inc)